MAR 11, 2021 8:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

A highly quantitative in vitro method for mechanistic genotoxicity screening

Sponsored by: Miltenyi Biotec
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Global Product Manager for Flow Cytometry Reagents
    Biography

      Before joining Miltenyi Biotec as a Global Product Manager for Flow Cytometry Reagents in 2018, Dr. Urmi Roy worked as a Post Doc at the Helmholtz Centre Braunschweig, Germany, where she specialized in mucosal immunology/gut microbiota. She received her Ph.D. in Immunology at the TU Braunschweig in 2017.

    • Founder and CEO of Toxys
      Biography

        Dr. Giel Hendriks is the founder and CEO of Toxys, a Dutch biotech company that develops and offers innovative in vitro assays for toxicological research. He completed his Ph.D in molecular cell biology at Utrecht University and worked as senior scientist in genetic toxicology at the Leiden University Medical Center.


      Abstract

      Date:  March 11, 2021

      Time: 8:00am (PST),  11:00am (EST)

       

      Identifying the toxicity profile of a compound is a necessity across industries and the various stages of drug development. Early stage mechanism-based in vitro assays can not only speed up the compound development pipeline, but also can reduce animal testing requirements. Information about the mode-of-action of genotoxic compounds can be vital for both screening and regulatory applications.

       

      In this webinar, Miltenyi Biotec and Toxys will highlight the potential of using flow cytometry for high content toxicity analysis. We will introduce the ToxTracker® Suite and you will learn about the opportunities, advantages and challenges faced when using this assay for mechanistic toxicity testing.

       

      Learning Objectives

      • Basics of in vitro toxicity and genotoxicity assays
      • How to achieve high-throughput, reliable flow cytometry to enhance genotoxicity analysis
      • The benefits of the ToxTracker assay for multiplexed mechanistic insight of toxicity

       

       

      Webinars will be available for unlimited on-demand viewing after live event.


      Show Resources
      You May Also Like
      DEC 02, 2020 8:00 AM PST
      C.E. CREDITS
      DEC 02, 2020 8:00 AM PST
      DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      NOV 16, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      OCT 08, 2020 7:00 AM PDT
      C.E. CREDITS
      OCT 08, 2020 7:00 AM PDT
      DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      APR 01, 2021 8:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      APR 01, 2021 8:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
      Loading Comments...
      Show Resources
      Event Countdown
      • 0 Days
      • 0 Hours
      • 0 Minutes
      • 0 Seconds
      Attendees
      • See more